SYNTHETIC DNA TEMPLATE FOR IN VITRO mRNA TRANSCRIPTION

Research output: Patent

Abstract

The present invention is related to the manufacturing of mRNA for use in immunotherapy or for use in immunotherapy screening or monitoring. Compared to existing methods the present approach is plasmid-free, fast and inexpensive, allowing screening of potential neoantigen in immunotherapy.
Original languageEnglish
Patent number WO2021185833A1
IPC A61K39/00,C12N15/10;
Publication statusPublished - 23 Sep 2021

Fingerprint

Dive into the research topics of 'SYNTHETIC DNA TEMPLATE FOR IN VITRO mRNA TRANSCRIPTION'. Together they form a unique fingerprint.

Cite this